St. Jude Medical downgraded to Market Perform from Outperform at William Blair William Blair downgraded St. Jude Medical citing uncertainty after the company said it expects to receive a warning letter from the FDA following a recent inspection of one of its cardiac rhythm management manufacturing facilities.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
St. Jude Medical's 3-D vessel reconstruction system approved in Europe St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform.